Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden.
Hiroyuki TatekawaHiroyuki UetaniAkifumi HagiwaraShadfar BahriCatalina RaymondAlbert LaiTimothy F CloughesyPhioanh L NghiemphuLinda M LiauWhitney B PopeNoriko SalamonBenjamin M EllingsonPublished in: Annals of nuclear medicine (2021)
Residual FDOPA hypermetabolic burden predicted OS for IDH wild-type gliomas, regardless of the tumor grade. Furthermore, removing hypermetabolic and CE regions may improve the prognosis.
Keyphrases